Catalyst Wire Dossier Catalyst Wire Dossier

Upifitamab Rilsodotin

upifitamab rilsodotin · Mersana Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Upifitamab Rilsodotin, covering 2023-10-26 to 2023-10-26. Get the full timeline:

Most recent: Clinical Trial Update: Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) [Phase 3]

See pricing